CoChat

The Phosphodiesterase‐4 (PDE 4) Inhibitor Rolipram Decreases Ethanol Seeking and Consumption in Alcohol‐Preferring Fawn‐Hooded Rats

Open access
Wen, Rui‐Ting, Zhang, Min, Qin, Wang‐Jun, Liu, Qing, Wang, Wei‐Ping, Lawrence, Andrew J., Zhang, Han‐Ting, Liang, Jian‐Hui · 2012 · Alcoholism: Clinical and Experimental Research
Cited by 71

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Alcohol dependence is a complex psychiatric disorder demanding development of novel pharmacotherapies. Because the cyclic adenosine monophosphate (cAMP) signaling cascade has been implicated in mediating behavioral responses to alcohol, key components in this cascade may serve as potential treatment targets. Phosphodiesterase‐4 (PDE 4), an enzyme that specifically catalyzes the hydrolysis of cAMP, represents a key point in regulating intracellular cAMP levels. Thus, it was of interest to determine whether PDE 4 was involved in the regulation of alcohol use and abuse. Methods: Male F awn‐H ooded (FH/W jd) rats were tested for 5% (v/v) ethanol (EtOH) and 10% (w/v) sucrose operant oral self‐administration following treatment with the selective PDE 4 inhibitor rolipram (0.0125, 0.025, or 0.05 mg/kg, subcutaneous [s.c.]); rolipram at higher doses (0.05, 0.1, and 0.2 mg/kg, s.c.) was tested to determine its impact on the intake of E t OH, sucrose, or water using the 2‐bottle choice drinking paradigm. Subsequent open‐field testing was performed to evaluate the influence of higher doses of rolipram on locomotor activity. Results: Acute administration of rolipram dose‐dependently reduced operant self‐administration of 5%E t OH, but had no effect on 10% sucrose responding. Time‐course assessment revealed significant decreases in E t OH consumption after rolipram (0.1, 0.2 mg/kg) treatment in continuous‐ and intermittent access to E t OH at 5% or 10%, respectively. Moreover, chronic rolipram treatment time‐dependently decreased 5%E t OH consumption and preference during treatment days and after the termination of rolipram administration. Rolipram at the highest doses (0.1 and 0.2 mg/kg) did decrease locomotor activity, but the effect lasted only 10 and 20 minutes, respectively, which did not likely alter long‐term E t OH drinking. Conclusions: These results suggest that PDE 4 plays a role in alcohol seeking and consumption behavior. Drugs interfering with PDE 4 may be a potential pharmacotherapy for alcohol dependence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1530-0277.2012.01845.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 71

Metadata

Authors
Wen, R., Zhang, M., Qin, W., Liu, Q., Wang, W., Lawrence, A. J., Zhang, H., & Liang, J.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
2012-06-04
Volume
36
Issue
12
Pages
2157-2167
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W2123260019
Cited by
71
References
6
FWCI
1.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Phosphodiesterase‐4 (PDE 4) Inhibitor Rolipram Decreases Ethanol Seeking and Consumption in Alcohol‐Preferring Fawn‐Hooded Rats. https://app.cochat.ai/papers/10.1111/j.1530-0277.2012.01845.x
The paper
Wen, R., Zhang, M., Qin, W., Liu, Q., Wang, W., Lawrence, A. J., Zhang, H., & Liang, J. (2012). The Phosphodiesterase‐4 (PDE 4) Inhibitor Rolipram Decreases Ethanol Seeking and Consumption in Alcohol‐Preferring Fawn‐Hooded Rats. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.2012.01845.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.